Abstract
BACKGROUND: Patients undergoing sacroiliac (SI) fusion can oftentimes experience significant improvements in pain and quality of life.
OBJECTIVE: To describe a novel application of robotic navigation to assist with minimally invasive SI joint fusion.
METHODS: Patients undergoing stand-alone SI joint fusion with ExcelsiusGPS robotic navigation from July 2020 through June 2021 were retrospectively enrolled. Baseline demographic and perioperative variables including radiation exposure, postoperative pain scores, and narcotic requirements in the postanesthesia care unit (PACU) were recorded. Length of stay and any postoperative complications were also noted.
RESULTS: A total of 10 patients (64.4 +/- 8.2 years, body mass index 28.7 +/- 4.8 kg/m(2)) met inclusion criteria. Seven patients (70.0%) were female, and there was a 6:4 split between left-sided and right-sided SI joint fusion. The total operative time was 54 +/- 9 minutes, and the estimated blood loss was 21.0 +/- 16.7 mL. The intraoperative radiation exposure was 13.7 +/- 6.2 mGy, and there were no complications. The average pain score in PACU was 5.2 +/- 1.0, and the average opioid administration in PACU was 27.6 +/- 10.3 morphine equivalents. Length of stay was 0.4 +/- 0.7 days, with 7 of 10 patients discharged on the same day as surgery. There were no readmissions. The average length of follow-up was 4.3 +/- 2.5 months. At the last follow-up, patients reported an average of 73.1% +/- 30.1% improvement in their preoperative pain.
CONCLUSION: Robot-navigated SI joint fusion is a feasible and reproducible method for addressing refractory SI joint disease. Further investigation on clinical outcomes and longterm fusion rates is needed, as are studies comparing robot-navigated SI joint fusion with more traditional techniques.